Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Kabiroc - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Kabiroc

Approved

STANDARD

Kabiroc

Fresenius Kabi Austria GmbH🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: fc58b4e9301bdcf8
Company: Fresenius Kabi Austria GmbH
Type: Standard

Approval Details

Approval Id: fc58b4e9301bdcf8
Drug Approval Philippines Name: Kabiroc
Product Name: Kabiroc
Registration Number: DR-XY49319
Brand Name: Kabiroc
Generic Name: Rocuronium Bromide
Dosage Form: Solution for Injection (IV)
Dosage Strength: 10 mg/mL
Manufacturer: Fresenius Kabi Austria GmbH
Importer: Fresenius Kabi Philippines, Inc.
Distributor: Fresenius Kabi Philippines, Inc.
Company Detail Path: /organization/fresenius-kabi-austria-gmbh
Issuance Date: 28 January 2025
Expiry Date: 28 January 2030
Pharmacologic Category: Muscle Relaxant
Classification: Prescription (Rx) Drug

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

fc58b4e9301bdcf8

Type

Standard

Back to Philippines FDA Approvals